This decision should be made collaboratively with your healthcare provider based on individual circumstances, treatment goals, and available options
Retatrutide Retatrutide is a novel weight loss treatment, manufactured by Eli Lilly, to treat obesity and type 2 diabetes
The FDA has approved Wegovy for adolescents 12 and older with obesity, but that path runs through in-person pediatric care
Weight loss and diabetes medications like GLP-1 receptor agonists (GLP-1s), including Ozempic (semaglutide), can help stabilize blood sugar levels, support weight management, and address related issues like cardiovascular disease
However, the goal is to improve overall health and to maximize the benefits of your GLP-1 agonists medication, so consider the following tips to ensure your success: Develop Healthy Eating Habits: While GLP-1 agonists help regulate appetite, combining them with a balanced diet rich in fruits, vegetables, lean proteins, and whole grains can enhance their effectiveness